(Q69868861)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2863504%20AND%20SRC:MED&resulttype=core&format=json

6 October 2019

title

Combined treatment with buserelin and cyproterone acetate in metastatic prostatic carcinoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2863504%20AND%20SRC:MED&resulttype=core&format=json

6 October 2019

author name string

J G Klign

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2863504%20AND%20SRC:MED&resulttype=core&format=json

6 October 2019

H J de Voogt

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2863504%20AND%20SRC:MED&resulttype=core&format=json

6 October 2019

F H Schröder

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2863504%20AND%20SRC:MED&resulttype=core&format=json

6 October 2019

F H de Jong

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2863504%20AND%20SRC:MED&resulttype=core&format=json

6 October 2019

language of work or name

English

0 references

publication date

1 August 1985

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2863504%20AND%20SRC:MED&resulttype=core&format=json

6 October 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2863504%20AND%20SRC:MED&resulttype=core&format=json

6 October 2019

volume

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2863504%20AND%20SRC:MED&resulttype=core&format=json

6 October 2019

issue

8453

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2863504%20AND%20SRC:MED&resulttype=core&format=json

6 October 2019

page(s)

493

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2863504%20AND%20SRC:MED&resulttype=core&format=json

LHRH-agonist treatment in metastatic prostate carcinoma

6 October 2019

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1016%2FS0140-6736%2885%2990415-5

inferred from DOI database lookup

7 January 2021

based on heuristic

Combined treatment with LHRH agonist and pure antiandrogen in advanced carcinoma of prostate

1 reference

Crossref

https://api.crossref.org/works/10.1016%2FS0140-6736%2885%2990415-5

inferred from DOI database lookup

7 January 2021

based on heuristic

Preliminary results on the clinical efficacy and safety of androgen inhibition by an LHRH agonist alone or combined with an antiandrogen in the treatment of prostatic carcinoma

1 reference

Crossref

https://api.crossref.org/works/10.1016%2FS0140-6736%2885%2990415-5

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0140-6736(85)90415-5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2863504%20AND%20SRC:MED&resulttype=core&format=json

6 October 2019

1 reference